StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BioAge Labs's enterprise value was -$50.03M on Nov 11, 2026, against $58.56M a year earlier. Over the last 2 years it ranged from -$211.05M to $705.89M, with a median of $5.81M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$50.03M-126.0%
2025Dec 31, 2025$192.64M–
2024Dec 31, 2024-$126.53M–

More BioAge Labs figures

See a number that looks wrong?